肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

PIN1,细胞周期和癌症

PIN1, the cell cycle and cancer

原文发布日期:2007-04-05

DOI: 10.1038/nrc2107

类型: Review Article

开放获取: 否

要点:

要点翻译:

英文摘要:

摘要翻译: 

原文链接:

文章:

PIN1,细胞周期和癌症

PIN1, the cell cycle and cancer

原文发布日期:2007-04-05

DOI: 10.1038/nrc2107

类型: Review Article

开放获取: 否

 

要点:

  1. PIN1 is a member of the evolutionarily conserved peptidyl-prolyl isomerase family of proteins, which encompasses the cyclophilins, FK506-binding proteins and the parvulins.
  2. PIN1 binds to and alters the conformation of phosphoproteins by catalysing the rapid cis to trans isomerization of proline amide bonds contained within the target proteins.
  3. The isomerization of proteins by PIN1 results in an alteration of protein structure and/or function, which is often coupled to a change in protein stabilization.
  4. PIN1 was originally identified as a cell cycle protein (mitotic). Subsequently, many cell-cycle regulatory proteins (G1/S, M and checkpoint) were identified as PIN1 binding partners. Given its ability to regulate these important proteins, PIN1 is suggested to act a molecular 'timer' of the cell cycle.
  5. PIN1 is overexpressed in some human cancers in correlation with cyclin D1 and β-catenin overexpression. Such correlations have led to the idea that PIN1 might be tumour promoting.
  6. The loss of PIN1 also promotes the stabilization of two important oncogenes, MYC and cyclin E. The germline deletion of Pin1 promotes rapid genomic instability in mouse embryo fibroblasts in a p53-dependent manner that encourages more aggressive Ras-induced transformation of these PIN1-null cells. Therefore, it has been suggested that PIN1 might act as a tumour suppressor.
  7. The contradictory experimental observations regarding the function of PIN1 in cancer remain enigmatic, but raise the possibility that PIN1 can either function as a tumour promoter or conditional tumour suppressor.

 

要点翻译:

  1. PIN1是进化上高度保守的肽基脯氨酰异构酶蛋白家族的成员,该家族包括亲环蛋白、FK506结合蛋白以及细小蛋白。
  2. PIN1通过催化靶蛋白中脯酰胺键的快速顺反异构化,结合并改变磷酸化蛋白质的构象。
  3. PIN1介导的蛋白质异构化会导致蛋白质结构和/或功能的改变,这种改变常与蛋白质稳定性的变化相关联。
  4. PIN1最初被鉴定为一种细胞周期蛋白(有丝分裂期)。随后,许多细胞周期调控蛋白(G1/S期、M期及检验点)被确认为PIN1的结合伴侣。鉴于其调控这些关键蛋白的能力,PIN1被认为在细胞周期中扮演分子"计时器"的角色。
  5. 在某些人类癌症中,PIN1与细胞周期蛋白D1和β-连环蛋白共同过表达。这种相关性使人们认为PIN1可能具有促肿瘤作用。
  6. 而PIN1的缺失也会促进两种重要癌基因MYC和细胞周期蛋白E的稳定。在小鼠胚胎成纤维细胞中,Pin1的种系缺失会以p53依赖性方式加速基因组不稳定性,从而促使这些PIN1缺失细胞发生更侵袭性的Ras诱导转化。因此,也有研究认为PIN1可能发挥肿瘤抑制因子功能。
  7. 关于PIN1在癌症中功能的这些矛盾实验观察仍存争议,但提示了PIN1可能兼具促癌因子和条件性抑癌因子的双重潜能。

 

英文摘要:

PIN1 is a peptidyl-prolyl isomerase that can alter the conformation of phosphoproteins and so affect protein function and/or stability. PIN1 regulates a number of proteins important for cell-cycle progression and, based on gain- and loss-of-function studies, is presumed to operate as a molecular timer of this important process. Therefore, it seems logical that alterations in the level of PIN1 can influence hyperproliferative diseases such as cancer. However, the precise role of PIN1 in cancer remains controversial.

摘要翻译: 

PIN1是一种肽基脯氨酰异构酶,能够改变磷酸化蛋白的构象,从而影响其功能和/或稳定性。PIN1调控多个与细胞周期进程相关的重要蛋白,基于功能获得与缺失研究,被认为在该过程中充当分子计时器。因此,PIN1水平的变化似乎理应会影响癌症等过度增殖性疾病。然而,PIN1在癌症中的确切作用仍存在争议。

原文链接:

PIN1, the cell cycle and cancer

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……